IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — GYRE

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents43.2937.5040.4036.4915.0515.8716.1029.792.236.928.1023.0975.3934.8259.1673.6283.04
Short-term Investments14.0612.3119.6517.8714.859.239.007.57----------2.505.3712.9023.96
Accounts Receivable27.7622.7625.8824.6320.15----------------0.561.111.971.01
Inventory11.4311.35--8.867.886.385.644.94------------------
Total Current Assets122.0791.7398.5891.2968.4554.8153.5262.725.137.6214.0130.2581.3136.7073.9696.83116.52
Property, Plant & Equipment27.2823.5723.6123.4023.5224.4423.6723.56----0.000.120.160.861.090.680.38
Intangible Assets4.534.634.854.965.080.180.190.20------------------
Total Non-current Assets*77.1870.2860.8161.3661.3470.4367.4159.294.834.774.740.772.073.574.574.962.56
Total Assets199.26162.01159.38152.65129.79125.24120.93122.019.9612.3918.7531.0283.3740.2778.54101.79119.08
Accounts Payable18.8115.4211.8014.9217.249.5510.5110.770.160.010.020.041.044.713.861.832.96
Total Current Liabilities28.6619.7915.9116.9218.9914.7215.5719.491.782.796.841.644.3113.1917.2515.5714.18
Total Non-current Liabilities*5.675.246.066.286.5012.0512.0113.754.664.614.550.000.000.000.551.050.81
Total Liabilities34.3425.0321.9723.2025.4926.7727.5833.246.457.4011.391.644.3113.1917.8016.6214.99
Retained Earnings(137.96)(77.67)(66.70)(70.31)(70.75)(73.35)(74.48)(78.01)(414.72)(413.15)(410.68)(370.48)(365.60)(417.23)(382.36)(357.13)(337.20)
Total Stockholder Equity107.93101.31101.9292.0368.1263.1860.3556.643.52(28.31)(25.95)29.3879.0627.0860.7485.16104.09

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue29.1122.5237.2030.5626.7722.0627.8725.4925.2327.1727.1586.3054.26--------0.792.442.30
Cost of Revenue2.211.231.741.631.150.891.180.960.770.981.25------------------
Gross Profit26.9021.2935.4528.9425.6221.1626.7024.5324.4626.1925.90------------------
Research & Development--6.744.822.363.433.103.712.783.362.18--0.420.320.59--0.801.879.7016.1420.35
Selling, General & Admin7.877.226.704.324.834.965.463.823.423.406.062.412.233.974.174.363.844.994.164.87
Total Operating Expenses43.4631.8740.7522.0123.4518.8926.1020.3021.1918.12172.061.622.54(0.18)40.275.17(51.53)15.5022.7527.53
Operating Income(14.36)(9.35)0.126.932.172.270.604.233.268.07(63.24)(1.62)(2.54)0.18(40.27)(5.17)51.53(14.70)(20.31)(25.23)
Pretax Income(14.43)(9.24)(0.07)7.632.244.640.773.936.0412.48(73.19)(1.58)(2.47)0.27(40.11)----------
Tax Provision(0.16)0.621.301.690.660.900.201.071.502.558.500.000.000.010.35----------
Net Income(14.27)(9.86)(1.37)5.941.583.730.572.864.549.94(81.69)(1.58)(2.47)0.26(40.45)(4.88)51.63(14.54)(20.33)(25.24)
Basic EPS(0.12)(0.10)(0.01)0.040.000.030.000.010.040.09(1.31)(0.04)(0.07)0.01(1.28)(0.16)1.64------
Diluted EPS(0.12)(0.10)(0.01)0.030.000.000.000.010.010.03(1.31)(0.04)(0.07)0.01(1.28)(0.16)1.64------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(16.73)3.18(5.62)4.682.09(0.13)(2.76)1.73(5.49)2.8837.80(3.22)(2.47)(6.22)(1.47)(7.28)(12.29)(12.05)(17.68)(21.60)
Capital Expenditures0.260.180.140.670.260.12(0.06)0.691.460.23------------------0.49
Free Cash Flow*(16.99)3.00(5.77)4.011.83(0.25)(2.69)1.03(6.95)2.65------------------(22.09)
Investing Cash Flow9.76(3.05)1.85(1.25)(3.04)1.97(2.00)(2.39)(8.27)(7.22)(24.97)0.004.800.410.050.0052.872.502.877.04
Financing Cash Flow(0.01)0.020.320.3722.351.340.960.320.160.6615.24(1.48)(3.50)(7.76)0.00(45.03)0.000.020.000.10

* Derived from reported values

Dividends Per Share

(USD)
MetricQ3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Dividends Per Share0.000.000.240.001.43